TLR Antagonist in Lupus An investigational TLR ) antagonist was effective in reducing biomarkers and clinical symptoms of SLE in a pilot trial, evidence that the innate immune system may hold the key to lupus pathophysiology. https://t.co/QSX3fRXRLs https://t.co/jt5nVer2ZQ